Why the study?
Does digitalis improve clinical outcomes in patients with congestive heart failure and sinus rhythm?
Does digitalis improve clinical outcomes in patients with congestive heart failure and sinus rhythm?
A critical appraisal of literature from 1960 to 1982 found very limited high-quality evidence supporting digitalis efficacy in heart failure with sinus rhythm, highlighting the need for better trials.
Answers are grounded in this paper and cite their sources.
Limited high-quality evidence restricts digitalis use in sinus-rhythm HF; leaves open benefits in select patients pending definitive trials.
Use of digitalis for the treatment of patients with congestive heart failure and sinus rhythm remains controversial. To ascertain the proper therapeutic role of digitalis, we have critically appraised the published clinical evidence of digitalis efficacy using standardized methodologic criteria. A search of the English literature from 1960 to 1982 identified 736 articles, of which 16 specifically addressed the clinical evaluation of digitalis therapy for patients with congestive heart failure and sinus rhythm. Only two double-blind, placebo-controlled trials provided clinically useful information. One study showed that digoxin therapy could be withdrawn successfully in elderly patients with stable congestive heart failure. The other showed that patients with chronic heart failure and an S3 gallop benefited from digoxin therapy.
No takes yet. Share an insight, caveat, or question.
Cynthia D. Mulrow (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: